Compare Wockhardt with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ABBOTT INDIA - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ABBOTT INDIA WOCKHARDT/
ABBOTT INDIA
 
P/E (TTM) x -37.7 59.7 - View Chart
P/BV x 0.8 17.7 4.7% View Chart
Dividend Yield % 0.0 0.4 1.2%  

Financials

 WOCKHARDT   ABBOTT INDIA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ABBOTT INDIA
Mar-19
WOCKHARDT/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,0128,834 11.5%   
Low Rs5325,458 9.7%   
Sales per share (Unadj.) Rs355.91,731.1 20.6%  
Earnings per share (Unadj.) Rs-60.3211.9 -28.4%  
Cash flow per share (Unadj.) Rs-46.8219.9 -21.3%  
Dividends per share (Unadj.) Rs0.0165.00 0.0%  
Dividend yield (eoy) %00.9 0.1%  
Book value per share (Unadj.) Rs257.8945.2 27.3%  
Shares outstanding (eoy) m110.6321.25 520.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.1 52.5%   
Avg P/E ratio x-12.833.7 -38.0%  
P/CF ratio (eoy) x-16.532.5 -50.8%  
Price / Book Value ratio x3.07.6 39.6%  
Dividend payout %030.7 -0.1%   
Avg Mkt Cap Rs m85,379151,848 56.2%   
No. of employees `0006.33.5 179.5%   
Total wages/salary Rs m9,3714,356 215.1%   
Avg. sales/employee Rs Th6,295.010,555.5 59.6%   
Avg. wages/employee Rs Th1,498.31,249.9 119.9%   
Avg. net profit/employee Rs Th-1,066.31,292.2 -82.5%   
INCOME DATA
Net Sales Rs m39,36936,786 107.0%  
Other income Rs m1,2021,133 106.1%   
Total revenues Rs m40,57137,919 107.0%   
Gross profit Rs m186,047 0.3%  
Depreciation Rs m1,495169 883.7%   
Interest Rs m2,55523 11,355.1%   
Profit before tax Rs m-2,8306,989 -40.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2572,485 10.3%   
Profit after tax Rs m-6,6694,503 -148.1%  
Gross profit margin %016.4 0.3%  
Effective tax rate %-9.135.6 -25.5%   
Net profit margin %-16.912.2 -138.4%  
BALANCE SHEET DATA
Current assets Rs m33,79627,610 122.4%   
Current liabilities Rs m26,9178,569 314.1%   
Net working cap to sales %17.551.8 33.8%  
Current ratio x1.33.2 39.0%  
Inventory Days Days7960 131.8%  
Debtors Days Days8927 325.7%  
Net fixed assets Rs m39,6641,057 3,752.9%   
Share capital Rs m553213 260.3%   
"Free" reserves Rs m27,96819,873 140.7%   
Net worth Rs m28,52220,086 142.0%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62029,409 277.5%  
Interest coverage x-0.1311.6 -0.0%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.51.3 38.6%   
Return on assets %-5.015.4 -32.7%  
Return on equity %-23.422.4 -104.3%  
Return on capital %-7.734.9 -22.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,807369 2,658.0%   
Fx outflow Rs m1,7894,918 36.4%   
Net fx Rs m8,019-4,549 -176.3%   
CASH FLOW
From Operations Rs m6844,991 13.7%  
From Investments Rs m6,302-2,570 -245.2%  
From Financial Activity Rs m-7,695-1,428 538.8%  
Net Cashflow Rs m-664993 -66.8%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.3 7.9 29.1%  
FIIs % 7.7 0.1 7,700.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 17.1 90.1%  
Shareholders   67,757 18,270 370.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 224 Points Higher; Realty and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended on a positive note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


May 29, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS